Page 1697 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

32. Fischer SA, Avery RK and the AST Infectious Disease 47. Shemie SD, Ross H, Pagliarello J, et al. Organ donor manage-
Community of Practice. Screening of donor and recipient prior ment in Canada: recommendations of the forum on medi-
to solid organ transplantation. Am J Transplant. 2009;9:S7-S18. cal management to optimize donor organ potential. CMAJ.
33. Tuttle-Newhall JE, Collins BH, Kuo PC, et al. Organ dona- 2006;174:S13-S32.
tion and treatment of the multiorgan donor. Curr Probl Surg. 48. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus con-
2003;40(5):266-310. ference report: maximizing use of organs recovered from the
34. Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal cadaver donor: cardiac recommendations, March 28-29, 2001,
City meeting to maximize the use of organs recovered from the Crystal City, Va. Circulation. 2002;106:836-841.
cadaver donor. Am J Transplant. 2002;2(8):701-711. 49. Pierre AF, Keshavjee S. Lung transplantation: donor and recipi-
35. Abbott KC, Bucci JR, Matsumoto CS, et al. Hepatitis C and renal ent critical care aspects. Curr Opin Crit Care. 2005;11:339-344.
transplantation in the era of modern immunosupression. J Am 50. Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung
Soc Nephl. 2003;14:2908-2918. transplantation donor-management protocol on lung donation
36. Dhillon GS, Levitt J, Mallidi H, et al. Impact of hepatitis B and recipient outcomes. Am J Respir Crit Care Med. 2006;174:
core antibody positive donors in lung and heart-lung trans- 710-716.
plantation: an analysis of the united network for ogan sharing 51. Kutsogiannis DJ, Pagliarello G, Doig C, et al. Medical manage-
database. Transplantation. 2009;88:842-846. ment to optimize donor organ potential: review of the literature.
37. Kalil AC, Levitsky J, Lyden E, et al. Meta-analysis: the efficacy of Can J Aneth. 2006;58:820-830.
strategies to prevent organ disease by cytomegalovirus in solid 52. Durand F, Renz JF, Alkofer B, et al. Report of the Paris consen-
organ transplant recipients. Ann Intern Med. 2005;143:870-880. sus meeting on expanded criteria donors in liver transplanta-
38. DiNardo CD, Tsai DE. Treatment advances in posttrans- tion. Liver Transpl. 2008;14:1694-1707.
plant lymphoproliferative disease. Curr Opin Hematol. 2010;17: 53. Feng S, Goodrich NP, Bragg-Greshamb JL, et al. Charasteristics
368-374. associated with liver graft failure: the concept of a donor risk
39. Delmonico FL. Cadaver donor screening for infectious agents in index. Am J Transplant. 2006;6:783-790.
solid organ transplantation. Clin Infect Dis. 2000;31:781-786. 54. Halldorson JB, Bakthavatsalam R, Fix O, et al. D-MELD, a sim-
40. Avery RK. Prophylactic strategies before solid-organ transplan- ple predictor of post liver transplant mortality for optimization
tation. Curr Opin Infect Dis. 2004;17:353-356. of donor/recipient matching. Am J Transplant. 2009;9:318-326.
41. Danziger-Isakov LA, Husain S, Mooney ML, et al. The novel 55. Salim A, Velmahos GC, Brown C, et al. J Trauma. 2006;58:
2009 H1N1 influenza virus pandemic: unique considerations 991-994.
for programs in cardiothoracic transplantation. J Heart Lung 56. Barklin A. Systemic inflammation in the brain-dead organ
Transplant. 2009;28:1341-1347. donor. Acta Anaesthesiol Scand. 2009;53:425-435.
42. Tilley PA, Fox JD, Lee B, et al. Screening of organ and tissue 57. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protec-
donors for West Nile virus by nucleic acid amplification—a tive strategy for organ donors on eligibility and availability of
three year experience in Alberta. Am J Transplant. 2008;8: lungs for transplantation: a randomized controlled trial. JAMA.
2119-2125. 2010;304:2620-2627.
43. Gandhi MJ, Strong DM. Donor-derived malignancy following 58. Singer P, Shapiro H, Cohen J, et al. Transplantation. 2005;80:
transplantation: a review. Cell Tissue Bank. 2007;8:267-286. 1363-1368.
44. Fiorentino M, D’Errico A, Corti B, et al. A multiorgan donor 59. Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor
cancer screening protocol: the Italian Emilia-Romagna region management increases the retrieval rate of lungs for transplan-
experience. Transplantation. 2003;76:1695-1699. tation. Ann Thorac Surg. 2008;85:278-286.
45. Kauffman MH, McBride MA, Delmonico FL. First report of the 60. Venkateswaran RV, Steeds RP, Quinn DW, et al. The haemo-
United Network for Organ Sharing Transplant Tumor Registry: dynamic effects of adjunctive hormone therapy in potential
donors with a history of cancer. Transplantation. 2000;70: heart donors: a prospective randomized double blind factorially
1747-1751. designed controlled trial. Eur Heart J. 2009;30:1771-1780.
46. Kauffman MH, McBride MA, Cherikh WS. Transplant
tumor registry: donors with central nervous system tumors.
Transplantation. 2002;73:579-582.

Section10-O-Ref.indd 2 1/21/2015 11:30:10 AM